Changing the Route of Administration to Improve Liver Transduction by Recombinant AAV-Based Vectors

被引：0
|
作者：
Zabaleta, Nerea [1 ]
Salas, David [1 ]
Majowicz, Anna [2 ]
Hernandez-Alcoceba, Ruben [1 ]
Sier-Ferreira, Valerie [2 ]
Prieto, Jesus [1 ]
Bilbao, Ignacio [1 ]
Gonzalez-Aseguinolaza, Gloria [1 ]
机构：
[1] FIMA, Pamplona, Spain
[2] UniQure, Amsterdam, Netherlands
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33109-4
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
300
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [41] ADMINISTRATION OF AAV-BASED ANTI-HIV IMMUNOADHESINS IN SHIV-INFECTED RHESUS MACAQUES
    Trible, Ronald
    Palesch, David
    Gravemann, Sophia
    Buening, Hildegard
    Kirchhoff, Frank
    Silvestri, Guido
    JOURNAL OF MEDICAL PRIMATOLOGY, 2014, 43 (05) : 400 - 400
  • [42] CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain
    Mathiesen, Sophie N.
    Lock, Jasmine L.
    Schoderboeck, Lucia
    Abraham, Wickliffe C.
    Hughes, Stephanie M.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 19 : 447 - 458
  • [43] AAV-based liver-targeted gene therapy for MNGIE: proposal for a clinical trial
    van den Ameele, J.
    Cutting, E.
    Marti, R.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A95 - A95
  • [44] Self-complementary AAV2 vectors improve transduction efficiency of corneal endothelial cells
    Gruenert, Anja Katharina
    Buening, Hildegard
    Schnoedt, Maria
    Schmeer, Marco
    Schleef, Martin
    Kruse, Friedrich E.
    Fuchsluger, Thomas Armin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [45] Safety and Efficacy of an AAV-Based Liver Gene Therapy for Crigler-Najjar Syndrome
    Collaud, Fanny
    Ronzitti, Giuseppe
    Bortolussi, Giulia
    Guianvarc'h, Laurence
    Veron, Philippe
    Charles, Severine
    Vidal, Patrice
    Sola, Marcelo Simon
    Leborgne, Christian
    Rundwasser, Stephanie
    Dejoint, Ludivine
    Goncalves, Delphine
    Van Wittenberghe, Laetitia
    Gjata, Bernard
    Martin, Samia
    Le Bec, Christine
    Bosma, Piter J.
    Muro, Andres F.
    Hebben, Matthias
    Mingozzi, Federico
    MOLECULAR THERAPY, 2017, 25 (05) : 188 - 189
  • [46] Site-Directed Mutagenesis Improves the Transduction Efficiency of Capsid Library-Derived Recombinant AAV Vectors
    Ran, Gai
    Chen, Xiao
    Xie, Yilin
    Zheng, Qingyun
    Xie, Jinyan
    Yu, Chenghui
    Pittman, Nikea
    Qi, Sixian
    Yu, Fa-Xing
    Agbandje-McKenna, Mavis
    Srivastava, Arun
    Ling, Chen
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 17 : 545 - 555
  • [47] Transduction of Primary Human Hepatocytes In Vitro and in Humanized Murine Livers In Vivo by Recombinant AAV3 Vectors
    Ling, Chen
    Wang, Yuan
    Zhang, Yuanhui
    Vercauteren, Koen
    Verhoye, Lieven
    Lu, Yuan
    Aslanidi, George
    Zhong, Li
    Gao, Guangping
    Ling, Changquan
    Meuleman, Philip
    Srivastava, Arun
    MOLECULAR THERAPY, 2014, 22 : S2 - S2
  • [48] Changing trends in the development of AAV-based gene therapies: a meta-analysis of past and present therapies
    Burdett, Tamara
    Nuseibeh, Samir
    GENE THERAPY, 2023, 30 (3-4) : 323 - 335
  • [49] Changing trends in the development of AAV-based gene therapies: a meta-analysis of past and present therapies
    Tamara Burdett
    Samir Nuseibeh
    Gene Therapy, 2023, 30 : 323 - 335
  • [50] Safety Profiling of AAV-Based Vectors In Vitro - Detection of Differentiated Transcriptomic Signatures in Transduced Primary Human Hepatocytes
    Rottensteiner, Hans Peter
    Galatenko, Vladimir
    Rosell-Hidalgo, Alicia
    Wurm, Stefanie
    Samatov, Timur
    Goussarov, Gleb
    Strielkov, Ievgen
    Douillard, Patrice
    Hoellriegl, Werner
    Walker, Paul
    Fritsch, Ruediger
    Scheiflinger, Friedrich
    Glantschnig, Helmut
    MOLECULAR THERAPY, 2023, 31 (04) : 417 - 417
12345